AQP3 and cancer: It was suggested that AQP3 may be a factor limiting the therapeutic action of 5′-DFUR, because of AQP3-deletion lowered the drug’s effectiveness - making it a possible chemotherapeutic target in the development of a cancer therapy combination approach.